| Literature DB >> 26167195 |
Cheng-Hung Lee1, Tsai-Chung Li2, Chia-I Tsai3, Shih-Yi Lin4, I-Te Lee5, Hsin-Jung Lee6, Ya-Chi Wu6, Yi-Chang Su7.
Abstract
Objective. Diabetic retinopathy (DR), the most common microvascular complication of diabetes mellitus (DM), can cause severe visual impairment and blindness. To prevent the development of DR, identifying the associated risk factors for patient classification is critical. We conducted a cross-sectional study to determine whether body constitution (BC) is an independent predictor of DR. Method. 673 type 2 DM (T2DM) patients were recruited from a medical center, all received DR examination and body constitution questionnaire to assess BC. Other risk factors for DR were also recorded, including life style, history of diabetes, and blood pressure, etc. Multiple logistic regression analysis was conducted to calculate the odds ratios (ORs) for DR. Results. The prevalence of DR was significantly lower in Yang deficiency patients compared with non-Yang deficiency patients (24.69% versus 38.18% P = 0.02). After adjusting for other risk factors, we observed that patients exhibiting Yang deficiency BC were less likely to present with DR (OR = 0.531; 95% confidence interval = 0.312-0.903, P = 0.018). Conclusion. In addition to traditional risk factors, Yang deficiency BC might be an independent predictor of DR among T2DM patients and the results can be used as evidence for traditional Chinese medicine patient classification.Entities:
Year: 2015 PMID: 26167195 PMCID: PMC4475744 DOI: 10.1155/2015/940898
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Figure 1The flowchart of the study.
Participant characteristics.
| Yang deficiency ( | Yin deficiency ( | Phlegm stasis ( | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Yes ( | No ( |
| Yes ( | No ( |
| Yes ( | No ( |
| |
| Age (years) | 57.57 ± 11.97 | 59.21 ± 10.60 | 0.20 | 60.01 ± 11.18 | 58.67 ± 10.63 | 0.16 | 59.21 ± 11.13 | 58.98 ± 10.74 | 0.86 |
| Female, | 59 (72.84) | 271 (45.78) | <0.001‡ | 100 (57.47) | 230 (46.09) | <0.01† | 57 (66.28) | 273 (46.51) | <0.001‡ |
| BMI (kg/m2) | 26.05 ± 4.26 | 25.67 ± 4.07 | 0.44 | 25.64 ± 3.69 | 25.74 ± 4.23 | 0.76 | 27.11 ± 4.68 | 25.51 ± 3.97 | <0.01† |
| WAIST (cm) | 88.04 ± 10.77 | 89.01 ± 10.46 | 0.43 | 87.83 ± 10.10 | 89.27 ± 10.61 | 0.12 | 91.98 ± 11.93 | 88.44 ± 10.20 | 0.01∗ |
| Lifestyle factors | |||||||||
| Smoke history, yes, | 4 (4.93) | 34 (5.74) | 0.77 | 8 (4.59) | 30 (6.01) | 0.49 | 6 (6.97) | 32 (5.45) | 0.57 |
| Alcohol usage, yes, | 0 (0) | 21 (3.54) | 0.09 | 2 (1.14) | 19 (3.80) | 0.08 | 0 (0) | 21 (3.57) | 0.07 |
| Exercise habits, yes, | 59 (72.83) | 475 (80.23) | 0.12 | 132 (75.86) | 402 (80.56) | 0.19 | 56 (65.11) | 478 (81.43) | <0.001‡ |
| Diabetic factors | |||||||||
| FBS (mg/dL) | 149.68 ± 60.61 | 144.98 ± 45.72 | 0.50 | 147.71 ± 53.87 | 144.8 ± 45.43 | 0.52 | 147.84 ± 41.99 | 145.21 ± 48.53 | 0.63 |
| HbAlc (%) | 7.87 ± 1.78 | 7.78 ± 1.67 | 0.67 | 7.86 ± 1.86 | 7.77 ± 1.61 | 0.58 | 8.08 ± 1.73 | 7.75 ± 1.67 | 0.08 |
| DMH (year) | 8.20 ± 7.40 | 8.28 ± 7.28 | 0.93 | 8.61 ± 7.34 | 8.15 ± 7.27 | 0.48 | 8.02 ± 6.82 | 8.31 ± 7.36 | 0.74 |
| OHA use, yes, | 75 (92.59) | 562 (94.93) | 0.38 | 165 (94.82) | 472 (94.58) | 0.90 | 81 (94.18) | 556 (94.71) | 0.84 |
| Insulin usage, yes, | 32 (39.51) | 147 (24.83) | <0.01† | 61 (35.06) | 118 (23.65) | <0.01† | 28 (32.56) | 151 (25.72) | 0.18 |
| Lipid profile | |||||||||
| TC (mg/dL) | 177.79 ± 39.74 | 175.46 ± 36.26 | 0.59 | 173.32 ± 35.84 | 176.58 ± 36.95 | 0.31 | 180.95 ± 41.93 | 174.97 ± 35.81 | 0.21 |
| TG (mg/dL) | 160.1 ± 120.29 | 156.82 ± 180.37 | 0.83 | 149.73 ± 91.91 | 159.82 ± 194.46 | 0.37 | 163.88 ± 136.23 | 156.24 ± 179.13 | 0.64 |
| HDL (mg/dL) | 52.24 ± 13.49 | 52.96 ± 14.78 | 0.68 | 51.68 ± 13.68 | 53.29 ± 14.93 | 0.21 | 51.51 ± 14.17 | 53.07 ± 14.69 | 0.36 |
| LDL (mg/dL) | 110.37 ± 31.97 | 106.9 ± 32.47 | 0.37 | 106.64 ± 33.85 | 107.56 ± 31.91 | 0.75 | 114.08 ± 36.41 | 106.33 ± 31.69 | 0.04∗ |
| Blood pressure | |||||||||
| SBP (mmHg) | 131.14 ± 17.05 | 131.58 ± 14.37 | 0.82 | 131.35 ± 15.57 | 131.59 ± 14.41 | 0.85 | 131.90 ± 16.21 | 131.47 ± 14.49 | 0.80 |
| DBP (mmHg) | 78.91 ± 11.31 | 78.38 ± 8.74 | 0.68 | 77.68 ± 9.93 | 78.70 ± 8.76 | 0.23 | 77.50 ± 10.09 | 78.58 ± 8.93 | 0.30 |
| GPT (U/L) | 29.28 ± 30.00 | 29.00 ± 23.53 | 0.94 | 28.43 ± 28.99 | 29.24 ± 22.57 | 0.74 | 32.52 ± 30.82 | 28.52 ± 23.27 | 0.25 |
| Renal parameters | |||||||||
| Microalbumin (mg/dL) | 27.85 ± 86.83 | 21.97 ± 72.16 | 0.56 | 28.12 ± 92.32 | 20.77 ± 66.49 | 0.34 | 27.47 ± 89.66 | 21.97 ± 71.52 | 0.59 |
| Cr (mg/dL) | 1.09 ± 0.46 | 1.14 ± 0.63 | 0.39 | 1.19 ± 0.63 | 1.12 ± 0.61 | 0.19 | 1.09 ± 0.49 | 1.14 ± 0.63 | 0.34 |
| eGFR (ml/min) | 69.56 ± 24.42 | 71.01 ± 21.52 | 0.57 | 67.22 ± 23.72 | 72.10 ± 21.07 | 0.01∗ | 70.64 ± 23.35 | 70.86 ± 21.67 | 0.93 |
| ALB/CR (ug/mg) | 475.24 ± 2008.6 | 233.91 ± 935.92 | 0.29 | 319.95 ± 1386.8 | 243.08 ± 1013.1 | 0.50 | 316.61 ± 1238.90 | 255.10 ± 1103.70 | 0.64 |
| Diabetic neuropathy, yes, | 63 (77.78) | 14 (2.36) | 0.08 | 48 (27.59) | 29 (5.81) | 0.01∗ | 64 (74.42) | 13 (2.21) | 0.25 |
Data were presented as mean ± SD for continuous variable and as number (%) for categorical variable.
P values were calculated using the chi-square test for categorical variable and t-test for continuous variable ∗ P < 0.05, † P < 0.01, and ‡ P < 0.001.
BMI, body mass index; FBS, fasting blood sugar; HbA1c, glycosylated hemoglobin; DMH, duration of diabetic mellitus; OHA, oral hypoglycemic agent; TC, total cholesterol; TG, total triacylglycerol; HDL, high density lipoprotein; LDL, low density lipoprotein; SBP, systolic blood pressure; DBP, diastolic blood pressure; GPT, glutamic pyruvic transaminase; Cr, creatinine; eGFR, estimated glomerular filtration rate; ALB/CR, microalbumin to creatinine ratio.
Prevalence of diabetic retinopathy according to body constitution.
| BC | DR | non-DR | Total |
|
|---|---|---|---|---|
|
|
|
| ||
| Yang deficiency | ||||
| Yes | 20 (24.69) | 61 (75.31) | 81 (100) | 0.02∗ |
| No | 226 (38.18) | 366 (61.82) | 592 (100) | |
| Yin deficiency | ||||
| Yes | 62 (35.63) | 112 (64.37) | 174 (100) | 0.77 |
| No | 184 (36.87) | 315 (63.13) | 499 (100) | |
| Phlegm stasis | ||||
| Yes | 24 (27.91) | 62 (72.09) | 86 (100) | 0.07 |
| No | 222 (37.82) | 365 (62.18) | 587 (100) |
BC: body constitution; DR: diabetic retinopathy. ∗ P < 0.05.
P values were calculated using the two-sided chi-square test.
Unadjusted and adjusted odds ratios and 95% CI for diabetic retinopathy according to constitution.
| Diabetic retinopathy, OR (95% CI) | ||||||
|---|---|---|---|---|---|---|
| Yang deficiency | Ying deficiency | Phlegm stasis | ||||
| OR (95% CI) |
| OR (95% CI) |
| OR (95% CI) |
| |
| Model 1 | 0.531 (0.312–0.903) | 0.018∗ | 0.948 (0.662–1.358) | 0.770 | 0.637 (0.386–1.049) | 0.075 |
| Model 2 | 0.536 (0.289–0.995) | 0.048∗ | 1.263 (0.832–1.917) | 0.273 | 0.735 (0.409–1.323) | 0.305 |
| Model 3 | 0.529 (0.282–0.995) | 0.048∗ | 1.164 (0.761–1.780) | 0.485 | 0.779 (0.427–1.422) | 0.416 |
| Model 4 | 0.531 (0.282–0.999) | 0.049∗ | 1.154 (0.754–1.768) | 0.510 | 0.746 (0.407–1.366) | 0.342 |
| Model 5 | 0.498 (0.262–0.947) | 0.034∗ | 1.099 (0.712–1.697) | 0.670 | 0.768 (0.415–1.421) | 0.401 |
| Model 6 | 0.472 (0.247–0.902) | 0.023∗ | 1.108 (0.715–1.717) | 0.645 | 0.812 (0.436–1.512) | 0.511 |
| Model 7 | 0.453 (0.234–0.875) | 0.019∗ | 1.057 (0.677–1.648) | 0.810 | 0.824 (0.438–1.550) | 0.548 |
Model 1 is unadjusted. Model 2 is adjusted for BC. Model 3 is additionally adjusted for sociodemographic factors. Model 4 is additionally adjusted for lifestyle. Model 5 is additionally adjusted for diabetic factors. Model 6 is additionally adjusted for blood pressure and lipid profile. Model 7 is additionally adjusted for renal parameters and diabetic neuropathy.
Analysis by logistic regression. ∗ P < 0.05.
BC: body constitution, including Yang deficiency, Ying deficiency, and Phlegm stasis. Sociodemographic factors: gender, age, BMI, and waist. Lifestyle: smoke and alcohol drinking history and exercise. Diabetic factors: FBS, HbA1c, DM duration, oral hypoglycemia agent, and insulin use. Blood pressure: SBP and DBP. Lipid profile: TG, HDL, and LDL. Renal parameters: GFR and microalbumin to creatinine ratio.